Dr. Subba R. Gollamudi, MD

Dr. Gollamudi practices at Ridge Lake Ambulatory Surgery Center in Memphis, Tennessee.

Dr. Gollamudi's NPI, 1154378735, was assigned on May 28, 2006. Dr. Gollamudi graduated from Yale University School of Medicine in 1987. Dr. Gollamudi holds Tennessee license MD0000021892.

Dr. Gollamudi's primary practice is Ridge Lake Ambulatory Surgery Center, at 825 Ridge Lake Blvd, Memphis, TN 38120. The practice phone is (901) 685-1088.

Dr. Gollamudi's primary practice is Ridge Lake Ambulatory Surgery Center in Memphis, Tennessee. Dmand AI also links Dr. Gollamudi to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gollamudi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gollamudi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gollamudi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Gollamudi's licenses on file in 3 states: Tennessee, Arkansas and Mississippi.

CMS data shows 3,115 Medicare services from Dr. Gollamudi across 15 procedure codes in 2024, for 1,031 Medicare patients. Medicare paid $510,056 for them.

CMS counts 1,031 Medicare patients who saw Dr. Gollamudi in 2024. The largest group is 65 to 74, with 559 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gollamudi's median patient age at 70, with 62% women.

In 2024, Dr. Gollamudi wrote 4,312 Medicare Part D claims for 1,047 patients. 60% of them were for generic drugs. CMS names the drug for 4,221 of them, across 23 drugs with 11 or more claims each, at $165,927 in total drug cost. In 2023, CMS named 2,406 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Gollamudi for performance year 2024, reported as part of a group. Dr. Gollamudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,098 procedures of cataract surgery by Dr. Gollamudi, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Gollamudi, published from 2011 to 2024. Dr. Gollamudi has published most often in Clin Ophthalmol. Dr. Gollamudi's most frequent co-authors are Michael Goldstein, MD, Ravi Harshad Patel, MD and Maria E. Rosselson, MD.

Dmand AI links Dr. Gollamudi to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Dry Eye Syndromes and Lacrimal Apparatus Diseases. Surface Ophthalmics, Inc. sponsors the most, 2.

CMS Open Payments shows 866 general payments to Dr. Gollamudi from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $80,077.

Dr. Gollamudi graduated from Yale University School of Medicine in 1987.